Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study

被引:49
|
作者
Bates, Emma L. [1 ]
Bragg, Christopher M. [2 ]
Wild, Jim M. [3 ]
Hatton, Matthew Q. F. [4 ]
Ireland, Rob H. [3 ,4 ]
机构
[1] Univ Sheffield, Dept Clin Oncol, Weston Pk Hosp, Sheffield Teaching Hosp NHS Trust, Sheffield S10 2SJ, S Yorkshire, England
[2] Weston Pk Hosp, Dept Radiotherapy, Sheffield, S Yorkshire, England
[3] Univ Sheffield, Acad Unit Radiol, Sheffield S10 2SJ, S Yorkshire, England
[4] Univ Sheffield, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England
关键词
Intensity-modulated radiotherapy; Non-small cell lung cancer; SPECT; Hyperpolarized helium-3 MRI; Radiotherapy treatment planning; INTENSITY-MODULATED RADIOTHERAPY; HYPERPOLARIZED HE-3 MRI; THERAPY ONCOLOGY GROUP; RADIATION-THERAPY; TUMOR-CONTROL; SPECT; IMRT; REGISTRATION; FEASIBILITY; TOXICITY;
D O I
10.1016/j.radonc.2009.05.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To investigate the incorporation of data from single-photon emission computed tomography (SPECT) or hyperpolarized helium-3 magnetic resonance imaging (He-3-MRI) into intensity-modulated radiotherapy (IMRT) planning for non-small cell lung cancer (NSCLC). Material and methods: Seven scenarios were simulated that represent cases of NSCLC with significant functional lung defects. Two independent IMRT plans were produced for each scenario; one to minimise total lung volume receiving >= 20 Gy (V-20), and the other to minimise only the functional lung volume receiving >= 20 Gy (FV20). Dose-volume characteristics and a plan quality index related to planning target volume coverage by the 95% isodose (V-PTV95/FV20) were compared between anatomical and functional plans using the Wilcoxon signed ranks test. Results: Compared to anatomical IMRT plans, functional planning reduced FV20 (median 2.7%, range 0.6-3.5%, p = 0.02), and total lung V-20 (median 1.5%, 0.5-2.7%, p = 0.02), with a small reduction in mean functional lung dose (median 0.4 Gy, 0-0.7 Gy, p = 0.03). There were no significant differences in target volume coverage or organ-at-risk doses. Plan quality index was improved for functional plans (median increase 1.4, range 0-11.8, p = 0.02). Conclusions: Statistically significant reductions in FV20, V-20 and mean functional lung dose are possible when IMRT planning is supplemented by functional information derived from SPECT or He-3-MRI. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 93 (2009) 32-36
引用
收藏
页码:32 / 36
页数:5
相关论文
共 50 条
  • [31] The evolving role of radiotherapy in non-small cell lung cancer
    Brown, Sean
    Banfill, Kathryn
    Aznar, Marianne C.
    Whitehurst, Philip
    Finn, Corinne Faivre
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1104):
  • [32] Postoperative radiotherapy in localized non-small cell lung cancer
    Rübe, C
    Nguyen, TP
    Fleckenstein, J
    Niewald, M
    [J]. LUNG CANCER, 2001, 33 : S29 - S33
  • [33] Whole brain radiotherapy for non-small cell lung cancer
    Cagney, Daniel N.
    Alexander, Brian M.
    Aizer, Ayal A.
    [J]. LANCET, 2017, 389 (10077): : 1394 - 1395
  • [34] Palliative radiotherapy regimens for non-small cell lung cancer
    Lester, J. F.
    Macbeth, F. R.
    Toy, E.
    Coles, B.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [35] Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
    Haslett, Kate
    Poettgen, Christoph
    Stuschke, Martin
    Faivre-Finn, Corinne
    [J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 328 - 335
  • [36] Radiotherapy for oligometastatic non-small cell lung cancer patients
    Levy, A.
    Roux, C.
    Mercier, O.
    Issard, J.
    Botticella, A.
    Barlesi, F.
    Le Pechoux, C.
    [J]. CANCER RADIOTHERAPIE, 2021, 25 (6-7): : 517 - 522
  • [37] RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER - AN OVERVIEW
    TUBIANA, M
    [J]. CHEST, 1989, 96 (01) : S85 - S87
  • [38] Role of radiotherapy in metastatic non-small cell lung cancer
    Feria, Sergio L.
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [39] Gemcitabine plus radiotherapy for non-small cell lung cancer
    Gregor, A
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 839 - 841
  • [40] Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer
    Erman, M
    Moretti, L
    Soria, JC
    Le Chevalier, T
    Van Houtte, P
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2004, 14 (04) : 315 - 321